Noveris Health Sciences is trading approximately 17% down at CA$0.90 today on profit-taking in a thinly traded micro-cap.
- The stock remains highly volatile following a sharp run-up and subsequent pullback throughout late July and early August.
- The decline comes despite a lack of new company-specific news or filings, diverging from a generally positive biotech sector and mixed broader market indices.